Silver Rock Financial’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23
Closed -$475K 117
2022
Q4
$475K Buy
+23
New +$469K 0.15% 103

Other funds holding CERO

Silver Rock Financial's CERO Position: Q1 2023 in Review

Silver Rock Financial sold out of CERo Therapeutics (CERO) in Q1 2023, closing a stake of 23 shares — an estimated $475K sold.

Silver Rock Financial first reported a position in CERO in Q4 2022 and held it in 1 quarter. The position peaked at $475K in Q4 2022. 15 funds tracked by Wall St. Rank hold CERO as of Q1 2023.

  • Silver Rock Financial reported no remaining CERo Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Silver Rock Financial sold 23 CERo Therapeutics shares in Q1 2023, an estimated $475K.
  • Silver Rock Financial first reported a position in CERo Therapeutics in Q4 2022 and held it in 1 quarter.
  • Silver Rock Financial's CERo Therapeutics position peaked at $475K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2023.

Based on Silver Rock Financial's 13F filing for Q1 2023, filed 15 May 2023.